Arvinas, Inc. (ARVN) — 8-K Filings

8-K Filings (30)

• 8-K Filing — Dec 8, 2025
• Arvinas, Inc. Files 8-K Report — Oct 24, 2025 Risk: low
  On October 24, 2025, Arvinas, Inc. filed an 8-K report. The filing primarily serves as a notification of other events and includes financial statements and exhi
• Arvinas, Inc. Files 8-K Report — Oct 20, 2025 Risk: low
  On October 20, 2025, Arvinas, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulatio
• Arvinas, Inc. Files 8-K Report — Oct 6, 2025 Risk: low
  On October 5, 2025, Arvinas, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation
• Arvinas, Inc. Files 8-K: Exit Costs, Reg FD, Other Events — Sep 17, 2025 Risk: medium
  On September 17, 2025, Arvinas, Inc. filed an 8-K report detailing cost associated with exit or disposal activities, a Regulation FD disclosure, and other event
• Arvinas, Inc. Files 8-K Report — Aug 8, 2025 Risk: low
  On August 8, 2025, Arvinas, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures, other events, and financial statements and exhibi
• Arvinas Appoints New Directors, Adjusts Executive Compensation — Jul 9, 2025 Risk: medium
  Arvinas, Inc. announced on July 9, 2025, changes in its board of directors and executive compensation. Specifically, the company elected two new directors, Dr.
• Arvinas, Inc. Files 8-K: Board Changes and Executive Compensation — Jun 30, 2025 Risk: medium
  On June 25, 2025, Arvinas, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the election of
• Arvinas, Inc. Files 8-K Report — Jun 13, 2025 Risk: low
  On June 13, 2025, Arvinas, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation F
• Arvinas, Inc. Files 8-K Report — Jun 6, 2025 Risk: low
  On June 6, 2025, Arvinas, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or
• Arvinas, Inc. Files 8-K Report — Jun 2, 2025 Risk: low
  Arvinas, Inc. filed an 8-K on June 2, 2025, reporting on events as of May 31, 2025. The filing includes information related to Regulation FD Disclosure, Other E
• Arvinas, Inc. Files 8-K Report — Apr 28, 2025 Risk: low
  On April 28, 2025, Arvinas, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation
• Arvinas, Inc. Files 8-K Report — Apr 4, 2025 Risk: low
  On April 4, 2025, Arvinas, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation F
• Arvinas, Inc. Files 8-K Report — Mar 11, 2025 Risk: low
  On March 11, 2025, Arvinas, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures, other events, and financial statements and exhibi
• Arvinas, Inc. Enters and Terminates Definitive Agreements — Jan 22, 2025 Risk: medium
  On January 15, 2025, Arvinas, Inc. entered into a material definitive agreement and also terminated a material definitive agreement. Specific details regarding
• Arvinas, Inc. Files 8-K Report — Jan 10, 2025 Risk: low
  On January 10, 2025, Arvinas, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulatio
• Arvinas, Inc. Enters Material Definitive Agreement — Jan 6, 2025 Risk: medium
  Arvinas, Inc. reported on December 31, 2024, an entry into a material definitive agreement. The filing does not disclose specific details of the agreement, such
• Arvinas, Inc. Signs Material Definitive Agreement — Dec 16, 2024 Risk: medium
  On December 13, 2024, Arvinas, Inc. entered into a material definitive agreement. The filing does not disclose specific details of the agreement, such as the co
• Arvinas, Inc. Files 8-K Report — Dec 10, 2024 Risk: low
  On December 10, 2024, Arvinas, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulati
• Arvinas, Inc. Files 8-K Report — Nov 19, 2024 Risk: low
  On November 18, 2024, Arvinas, Inc. filed an 8-K report to disclose other events. The filing does not contain specific details regarding material events, agreem
• Arvinas, Inc. Signs Material Definitive Agreement — Aug 20, 2024 Risk: medium
  On August 15, 2024, Arvinas, Inc. entered into a Material Definitive Agreement. The filing does not disclose specific details of the agreement, such as the coun
• Arvinas Appoints New CMO, Elects Director — Jun 24, 2024 Risk: low
  On June 22, 2024, Arvinas, Inc. announced the appointment of Dr. Heidi L. Feldman as Chief Medical Officer and the election of Ms. Sarah E. Kelly to its Board o
• Arvinas, Inc. Signs Material Definitive Agreement — Jun 18, 2024 Risk: medium
  On June 14, 2024, Arvinas, Inc. entered into a Material Definitive Agreement. The filing does not disclose specific details of the agreement, such as the counte
• Arvinas Appoints New CMO, Dr. McCluskey — Jun 17, 2024 Risk: medium
  On June 15, 2024, Arvinas, Inc. announced the departure of Dr. Robert T. Small from his role as Chief Medical Officer. The company also announced the appointmen
• Arvinas Partners with Eli Lilly for $1.08B Drug Development Deal — May 30, 2024 Risk: medium
  Arvinas, Inc. announced on May 28, 2024, that it has entered into a collaboration and license agreement with Eli Lilly and Company. This agreement focuses on th
• Arvinas, Inc. Files 8-K Report — May 16, 2024 Risk: low
  On May 16, 2024, Arvinas, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation FD
• Arvinas, Inc. Files 8-K for Material Definitive Agreement — Apr 11, 2024 Risk: medium
  On April 10, 2024, Arvinas, Inc. entered into a Material Definitive Agreement. The filing also includes Regulation FD Disclosure and Financial Statements and Ex
• Arvinas Board Changes and Executive Compensation Update — Mar 18, 2024 Risk: low
  On March 14, 2024, Arvinas, Inc. filed an 8-K report detailing the departure of Dr. Timothy M. Dougherty from its Board of Directors. The filing also announced
• Arvinas Files 8-K on Officer Changes and Compensation — Feb 20, 2024 Risk: medium
  Arvinas, Inc. filed an 8-K on February 20, 2024, reporting an event that occurred on February 15, 2024. The filing pertains to Item 5.02, which covers the depar
• Arvinas Files 8-K for Jan 7 Event; Details Pending — Jan 8, 2024
  Arvinas, Inc. filed an 8-K on January 8, 2024, reporting an event that occurred on January 7, 2024. This filing is a standard 'Other Events' report, indicating

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX